Vincamine

규격

1617-90-9CAS 번호

216-576-3EC 번호

methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraene-17-carboxylateIUPAC 명칭

C21H26N2O3화학식

354.4 g/mol분자량

vincamine; 1617-90-9; Pervincamine; Arteriovinca; Angiopac; Vincafor; Vincamidol; Novicet; Methyl vincaminate; Oxygeron; Vincagil; Equipur; Vincafolina; Tripervan; Vincadar; Ocu-vinc; Vincamina; Vincimax; Perval; Pervone; Vincaminum; Vraap; DTXSID9040134; Vinodrel retard; Cetal retard; 996XVD0JHT; Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3alpha,14beta,16alpha)-; NSC-91998; CHEBI:9985; DTXCID7020134; methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate; methyl 14beta-hydroxy-14,15-dihydro-3alpha,16alpha-eburnamenine-14alpha-carboxylate; methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo(9.6.2.0^(2,7).0^(8,18).0^(15,19))nonadeca-2,4,6,8(18)-tetraene-17-carboxylate; methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo(9.6.2.02,7.08,18.015,19)nonadeca-2,4,6,8(18)-tetraene-17-carboxylate; methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate; RefChem:194264; C04AX07; 216-576-3; Devincan; Minorine; (+)-Vincamine; Vincamin; Anasclerol; Monorin; Devinkan; Vincasaunier; Decincan; Vincapront; Vinkametrin; Minorin; MFCD00078054; Vincachron; Vincapan; Vinca-Ecobi; Vinca-Minor; Alkaloid obtained from Vinca minor; Anasclerol (base); 14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester; Vincamine (INN); Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methylester, (3a,14b,16a)-; VINCAMINE [INN]; Methyl (41S,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate; Vincamina [DCIT]; Vincamine base; Vincaminum [INN-Latin]; Vincamine [INN:BAN:DCF]; HSDB 7150; EINECS 216-576-3; NSC 91998; UNII-996XVD0JHT; Pervincamine;; Vincamarine;; Minorine;; Vincamine CRS; NCGC00094824-01; Prestwick_495; CAS-1617-90-9; Cetal retard (TN); Vincamine, 98%; Vincamine (Standard); VINCAMINE [MI]; VINCAMINE [HSDB]; Prestwick0_000271; Prestwick1_000271; Prestwick2_000271; Prestwick3_000271; VINCAMINE [MART.]; VINCAMINE [WHO-DD]; Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3alpha,14beta,16.); BSPBio_000142; GTPL349; MLS002154249; SCHEMBL147179; SPBio_002361; BPBio1_000158; CHEMBL1165342; SCHEMBL29710919; VINCAMINE [EP MONOGRAPH]; BCBcMAP01_000080; HY-B1021R; HMS1568H04; HMS2095H04; HMS2268C20; HMS3712H04; HY-B1021; Tox21_111342; Tox21_301968; s3891; Vincamine for system suitability CRS; AKOS015896471; Tox21_111342_1; CCG-208544; CS-4536; DB13374; EBC-618387; FV65205; KS-5179; SMP1_000314; Vincamine, analytical reference material; NCGC00184983-01; NCGC00184983-03; NCGC00255542-01; AC-22625; SMR000112509; SY057985; NS00006858; C09251; D08677; F463487; Q416225; BRD-K40902647-001-03-7; Vincamine Working Standard (Secondary Reference Standard); Methyl 14beta-hydroxy-3alpha,16alpha-14,15-dihydroeburnamenine-14alpha-carboxylate; (3alpha,14beta,16alpha)-14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester; (4(1)S,12S,13aS)-methyl 13a-ethyl-12-hydroxy-2,3,4(1),5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate; (41S,12S,13aS)-methyl 13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate; Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-,methyl ester, (3alpha,14beta,16alpha)-; methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0?,?.0?,??.0??,??]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate; methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2(7),3,5,8(18)-tetraene-17-carboxylate; methyl(15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate; Methyl(41S,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate동의어